Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Pfizer Should Put Thoughts of a Somaxon Acquisition to Sleep
BNET Pharma
Monday, April 12, 2010 - 4:54pm
tags:
Pfizer, Somaxon, Silenor, M&A
[video]Healthy Growth Prospects for This Pharma Pick
Yahoo/Morningstar
Monday, April 12, 2010 - 4:52pm
tags:
Novartis
FDA approves Mylan's drug applications
Bizjournals.com
Monday, April 12, 2010 - 12:12pm
tags:
FDA, Mylan, antihypertensives, generics, Merck, Wellbutrin, GSK, Hyzaar
Stop the Presses: Hapless Biotech Genzyme May Actually Be Doing Something Right
BNET Pharma
Monday, April 12, 2010 - 12:09pm
tags:
Genzyme, Carl Icahn
Hospira offers competing bid to buy Javelin Pharma
Yahoo/AP
Monday, April 12, 2010 - 12:02pm
tags:
Hospira, Javelin, M&A, Myriad
Pharmaceutical Sales Healthcare Reform Survival Guide
Pharmareform
Monday, April 12, 2010 - 11:41am
tags:
healthcare reform
Inhibitex will continue with shingles study
Yahoo/AP
Monday, April 12, 2010 - 11:39am
tags:
Inhibitex, shingles
Vernalis CEO insists he's hunting for new drug deals
Fierce Biotech
Monday, April 12, 2010 - 10:49am
tags:
Vernalis, M&A
Javelin rockets, Myriad gains on merger termination
Marketwatch
Monday, April 12, 2010 - 10:47am
tags:
Javelin, Myriad, Hospira
Yes+Yes=No? Forest's Daxas and the Pull of Comparative Studies
InVivo
Monday, April 12, 2010 - 9:46am
tags:
comparative effectiveness, Forest Labs, Daxas, FDA
AngioDynamics: Warming Up or Cooling Off?
Motley Fool
Monday, April 12, 2010 - 9:45am
tags:
AngioDynamics
Novartis Sex-Discrimination Case: The Horrible Downside of Tolerating "Bad Apples"
BNET Pharma
Monday, April 12, 2010 - 9:44am
tags:
Novartis, discrimination
Paper: Roche, Novartis threaten to leave UK
Fierce Pharma
Monday, April 12, 2010 - 9:42am
tags:
UK, Roche, Novartis
Celgene Paints a Bright Future in Its R&D Update
Seeking Alpha
Monday, April 12, 2010 - 9:41am
tags:
Celgene, R&D
Positive Data from Optimer
Yahoo/Zacks.com
Monday, April 12, 2010 - 9:39am
tags:
Optimer, fidaxomicin, Sanofi, ViroPharma
Nycomed Still Plans IPO
WSJ Online
Monday, April 12, 2010 - 9:38am
tags:
IPOs, Nycomed, Daxas, Forest Labs
Lilly’s Once-Weekly Byetta May Have Cancer Risk
Pharmalot
Monday, April 12, 2010 - 9:37am
tags:
Eli Lilly, Byetta, diabetes, cancer
Sanofi-Aventis Places Large Bet on Diabetes Drug Candidate
Seeking Alpha
Monday, April 12, 2010 - 9:06am
tags:
diabetes, Novo Nordisk, Sanofi, Pancreate, CureDM
Keryx Biopharmaceuticals Could Easily Triple Within the Next Year
Seeking Alpha
Monday, April 12, 2010 - 9:04am
tags:
Dendreon, Keryx, Merck, Pfizer, Ranbaxy, Sanofi
Tongjitang Receives Buyout Offer From CEO and Fosun
Seeking Alpha
Sunday, April 11, 2010 - 12:46pm
tags:
Tongjitang, Fosun Pharmaceutical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.